Protective effect of corynoline in a murine allergic rhinitis model via inhibition of caspase‐1/NF‐κB
Sign Up to like & getrecommendations! Published in 2020 at "Archiv der Pharmazie"
DOI: 10.1002/ardp.202000231
Abstract: Allergic rhinitis (AR) is a serious public health concern worldwide. Therefore, the present study was conducted to scrutinize the protective effect of corynoline (COR) against ovalbumin (OVA)‐induced AR in BALB/c mice. The effect of COR… read more here.
Keywords: effect corynoline; allergic rhinitis; protective effect; effect ... See more keywords
Direct and indirect costs of allergic and non‐allergic rhinitis to adults in Beijing, China
Sign Up to like & getrecommendations! Published in 2022 at "Clinical and Translational Allergy"
DOI: 10.1002/clt2.12148
Abstract: Abstract Background Chronic rhinitis is generally classified as either allergic rhinitis (AR) or non‐allergic rhinitis (NAR). There is currently no report on the economic burden of AR and NAR in Beijing, China. Methodology A total… read more here.
Keywords: beijing china; rhinitis; non allergic; indirect costs ... See more keywords
Symptom control and health‐related quality of life in allergic rhinitis with and without comorbid asthma: A multicentre European study
Sign Up to like & getrecommendations! Published in 2023 at "Clinical and Translational Allergy"
DOI: 10.1002/clt2.12209
Abstract: Abstract Background Allergic rhinitis (AR) is a major non‐communicable disease that affects the health‐related quality of life (HRQoL) of patients. However, data on HRQoL and symptom control in AR patients with comorbid asthma (AR +… read more here.
Keywords: symptom control; control; asthma; comorbid asthma ... See more keywords
IL2-inducible T-cell kinase inhibitor ibrutinib reduces symptoms and Th2 differentiation in mouse allergic-rhinitis model.
Sign Up to like & getrecommendations! Published in 2021 at "Drug development research"
DOI: 10.1002/ddr.21884
Abstract: Th2 and Th17 immune response contribute to allergic rhinitis (AR) development. Targeting Th2 and Th17 response has been shown to ameliorate AR. Ibrutinib is an inhibitor for IL2-inducible T-cell kinase, which can promote Th2 and… read more here.
Keywords: allergic rhinitis; ibrutinib; model; th2 th17 ... See more keywords
Histamine H1 receptor gene polymorphism acts as a biological indicator of the prediction of therapeutic efficacy in patients with allergic rhinitis in the Chinese Han population
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Cellular Biochemistry"
DOI: 10.1002/jcb.27278
Abstract: H1‐antihistamine has been shown to be effective in treating patients with allergic rhinitis (AR), but its mechanism is still uncertain. We investigated effects of histamine H1 receptor (HRH1) gene polymorphisms on the efficacy of oral… read more here.
Keywords: allergic rhinitis; chinese han; efficacy; gene ... See more keywords
Aberrant expressions of circulating lncRNA NEAT1 and microRNA‐125a are linked with Th2 cells and symptom severity in pediatric allergic rhinitis
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Clinical Laboratory Analysis"
DOI: 10.1002/jcla.24235
Abstract: Long noncoding RNA nuclear enriched abundant transcript 1 (lnc‐NEAT1) and its target microRNA‐125a (miR‐125a) are reported to regulate immune and inflammation process in allergic rhinitis (AR). Hence, this study intended to investigate the correlation between… read more here.
Keywords: expressions circulating; allergic rhinitis; microrna 125a; circulating lncrna ... See more keywords
Aberrant expression of long non‐coding RNA PVT1 in allergic rhinitis children: Correlation with disease risk, symptoms, and Th1/Th2 imbalance
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Clinical Laboratory Analysis"
DOI: 10.1002/jcla.24281
Abstract: Long non‐coding RNA plasmacytoma variant translocation 1 (lnc‐PVT1) exacerbates inflammation and induces T helper (Th) 1/Th2 imbalance in allergic diseases, but its clinical role in allergic rhinitis (AR) remains unclear. Hence, we conducted this study… read more here.
Keywords: long non; th2 imbalance; allergic rhinitis; pvt1 ... See more keywords
Effects of rosmarinic acid on the inflammatory response in allergic rhinitis rat models after PM2.5 exposure
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Clinical Laboratory Analysis"
DOI: 10.1002/jcla.24316
Abstract: Studies have shown the promising prospects of rosmarinic acid (RosA) for the prevention and treatment of allergic diseases. read more here.
Keywords: response allergic; rosmarinic acid; acid inflammatory; inflammatory response ... See more keywords
Cell division cycle 42 reflects disease risk, symptoms, Th1/Th2 disproportion, and its short‐term variation indicates symptom amelioration after treatment in allergic rhinitis patients
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Clinical Laboratory Analysis"
DOI: 10.1002/jcla.24684
Abstract: Cell division cycle 42 (CDC42) modulates the pathogenesis of allergic rhinitis (AR) through regulating immunity, allergic response, and T‐helper (Th)1/Th2 imbalance. This study aimed to evaluate the potential of CDC42 to reflect disease risk, symptom… read more here.
Keywords: division cycle; symptom amelioration; cell division; th1 th2 ... See more keywords
Association between IL1RL1 gene polymorphisms and allergic rhinitis risk in the Chinese Han population
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Clinical Laboratory Analysis"
DOI: 10.1002/jcla.24747
Abstract: Although it has been confirmed that IL1RL1 is involved in the occurrence of allergic rhinitis (AR), the role of IL1RL1 gene single nucleotide polymorphisms (SNPs) in AR is still unclear. read more here.
Keywords: gene polymorphisms; il1rl1 gene; association il1rl1; allergic rhinitis ... See more keywords
Pharmacokinetics and Concentration-Response of Dupilumab in Patients with Seasonal Allergic Rhinitis.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of clinical pharmacology"
DOI: 10.1002/jcph.2004
Abstract: Patients with moderate to severe allergic rhinitis may benefit from subcutaneous immunotherapy (SCIT), despite the risk of systemic allergic reaction. Dupilumab is a fully human monoclonal antibody that blocks the shared receptor component for interleukin… read more here.
Keywords: dupilumab; concentration response; allergic rhinitis; seasonal allergic ... See more keywords